Patients with hepatic or renal insufficiency. Children.
Patients hypersensitive to fenofibrate or to any of the excipients of Supralip NT 145. In case of known photoallergy or phototoxic reaction during treatment with fibrates or ketoprofen, and in gallbladder disease.
Patients allergic to peanut or arachis oil or soya lecithin or related products due to the risk of hypersensitivity reactions.
Use in Pregnancy & Lactation: Supralip NT 145 may not be used during pregnancy and lactation as there are no data in pregnant women and on the excretion of fenofibrate and its metabolites into breast milk.